The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is anticipated to expand at a CAGR of 6.2% during the forecast period from 2023 to 2033. This growth trajectory is expected to propel the market to an impressive USD 8,654.1 Million by 2033. The rise in …